<DOC>
	<DOCNO>NCT00498082</DOCNO>
	<brief_summary>EsophyX promise endoscopic treatment gastro-esophageal reflux disease . It know whether pre- per-operative anatomic pathophysiological finding may influence outcome . The aim trial study series parameter acquire pre-therapeutic work-up procedure influence outcome procedure .</brief_summary>
	<brief_title>Determinants Efficacy EsophyX Treatment Gastro-Esophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>Patients consider EsophyX treatment GERD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>